We are live on !
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$79.5B
Turnover
11.02%
1-Year Est. Return
27.1%
This Fund
S&P 500
This Quarter Est. Return
+15.68%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.22%
AUM
$79.5B
AUM Growth
+$7.93B
(+11%)
Cap. Flow
-$643M
Cap. Flow % of AUM
Cap. Flow %
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
16.98%
Holding
4,611
New
312
Increased
1,846
Reduced
2,170
Closed
196
Avg Time Held
5.9
years
Top 10 Avg Time Held
8.7
years
Top 20 Avg Time Held
7.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$70M |
| 2 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$65.3M |
| 3 |
Fidelity Fundamental Large Cap Growth ETF
FFLG
|
+$50M |
| 4 |
Eli Lilly
LLY
|
+$42.5M |
| 5 |
SpaceX
SPCX
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$122M |
| 2 |
NVIDIA
NVDA
|
+$99.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.3M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$79.7M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$69.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.62% |
| 2 | Technology | 12.02% |
| 3 | Financials | 4.01% |
| 4 | Industrials | 3.47% |
| 5 | Consumer Discretionary | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4351
NeuroSense Therapeutics
NRSN
$4.63M
| $16.4K | ﹤0.01% |
1,139
| – | – |
2024 Q3
7 quarters
|
|
4352
Hyperfine
HYPR
$77M
| $16.1K | ﹤0.01% |
11,910
-8,000
| -40% | -$11.6K |
2024 Q4
6 quarters
|
|
4353
PharmaCyte Biotech
PMCB
$3.76M
| $15.6K | ﹤0.01% |
20,255
+9,942
| +96% | +$7.48K |
2026 Q1
1 quarter
|
|
4354
Defi Technologies
DEFT
$162M
| $15.1K | ﹤0.01% |
29,284
-1,000
| -3% | -$678 |
2025 Q2
4 quarters
|
|
4355
BRC Inc
BRCC
$158M
| $14.9K | ﹤0.01% |
1,340
+107
| +9% | +$1.32K |
2022 Q1
17 quarters
|
|
4356
Akebia Therapeutics
AKBA
$156M
| $14.4K | ﹤0.01% |
12,610
| – | – |
2023 Q4
10 quarters
|
|
4357
Milestone Scientific
MLSS
$28.2M
| $14.4K | ﹤0.01% |
44,782
| – | – |
2026 Q1
1 quarter
|
|
4358
GEE Group
JOB
$22.9M
| $13.9K | ﹤0.01% |
66,200
| – | – |
2023 Q1
13 quarters
|
|
4359
Goldgroup Mining
GORO
$566M
| $12.9K | ﹤0.01% |
+2,551
| New | +$13.9K |
2026 Q2
0 quarters
|
|
4360
GoldMining Inc
GLDG
$161M
| $12.8K | ﹤0.01% |
14,135
| – | – |
2026 Q1
1 quarter
|
|
4361
Cardiol Therapeutics
CRDL
$140M
| $12.2K | ﹤0.01% |
11,495
+395
| +4% | +$500 |
2025 Q3
3 quarters
|
|
4362
Hain Celestial
HAIN
$14.3M
| $11.9K | ﹤0.01% |
21,269
| – | – |
2025 Q4
2 quarters
|
|
|
YARW
4363
Yarrow Bioscience
YARW
$165M
| $11.9K | ﹤0.01% |
366
| – | – |
2024 Q3
7 quarters
|
|
|
FFAI
4364
Faraday Future Intelligent Electric
FFAI
$3.93M
| $11.6K | ﹤0.01% |
337
+100
| +42% | +$4.94K |
2026 Q1
1 quarter
|
|
4365
Dyadic International
DYAI
$16.1M
| $11.3K | ﹤0.01% |
12,579
| – | – |
2021 Q2
20 quarters
|
|
4366
cbdMD
YCBD
$4.18M
| $10.9K | ﹤0.01% |
16,255
| – | – |
2025 Q2
4 quarters
|
|
4367
Humacyte
HUMA
$115M
| $10.4K | ﹤0.01% |
13,330
-2,869
| -18% | -$2.66K |
2023 Q3
11 quarters
|
|
4368
Blink Charging
BLNK
$57.3M
| $9.9K | ﹤0.01% |
15,419
-1,574
| -9% | -$1.14K |
2020 Q3
23 quarters
|
|
4369
Prairie Operating Co
PROP
$41.9M
| $9.8K | ﹤0.01% |
13,530
| – | – |
2025 Q2
4 quarters
|
|
4370
AI Financial Corp
AIFC
$41.3M
| $9.6K | ﹤0.01% |
16,500
+3,000
| +22% | +$2.51K |
2025 Q3
3 quarters
|
|
4371
SunPower Inc
SPWR
$73M
| $9.6K | ﹤0.01% |
+14,000
| New | +$13.7K |
2026 Q2
0 quarters
|
|
4372
Orion Digital Corp
ORIO
$21.5M
| $9.38K | ﹤0.01% |
+11,032
| New | +$10.6K |
2026 Q2
0 quarters
|
|
4373
IGC Pharma
IGC
$25.6M
| $9.07K | ﹤0.01% |
33,348
-500
| -1% | -$148 |
2024 Q2
8 quarters
|
|
4374
Microvision
MVIS
$34.9M
| $8.87K | ﹤0.01% |
1,809
+1,014
| +128% | +$8.36K |
2024 Q2
8 quarters
|
|
|
HLSQ
4375
Tessera Defense and Homeland Security Inc.
HLSQ
$2.45M
| $8.14K | ﹤0.01% |
+2,341
| New | +$26.9K |
2026 Q2
0 quarters
|
|
Similar funds
Commonwealth Equity Services's Q2 2026 Portfolio in Review
As of Q2 2026, Commonwealth Equity Services held 4,611 positions worth $79.5B, up 11% from $71.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Commonwealth Equity Services's Q2 2026 filing shows 312 new, 1,846 increased, 2,170 reduced and 196 closed positions. Its largest new stake was SpaceX: 238,120 shares worth $40.7M. The largest sale was Apple, an estimated $122M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 66% a quarter earlier, followed by Technology and Financials.
- Commonwealth Equity Services's largest Q2 2026 buy was SpaceX: 238,120 shares worth $40.7M.
- Commonwealth Equity Services added most to Invesco NASDAQ 100 ETF in Q2 2026, an estimated $70M increase.
- Commonwealth Equity Services's biggest Q2 2026 reduction was Apple, cutting an estimated $122M.
- Commonwealth Equity Services fully exited Convergence Long/Short Equity ETF in Q2 2026, selling an estimated $7.88M.
- Commonwealth Equity Services's ten largest holdings make up 17% of its $79.5B portfolio in Q2 2026.
- Commonwealth Equity Services opened 312 new positions and closed 196 in Q2 2026.
- Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $79.5B.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.